Work

1036 a 24-week, Parallel-group, Open-label, Randomized Clinical Trial Comparing the Early Antiviral Efficacy of Telbivudine and Entecavir in the Treatment of Hbeag-positive Chronic Hepatitis B

FWCI: 0.233
Cites:
Cited by: 1
Related to: 10